Entrar Registro gratuito

Theratechnologies Receita A/A

Qual é o Receita A/A de Theratechnologies?

O Receita A/A de Theratechnologies, Inc. é 3.63%

Qual é a definição de Receita A/A?

O crescimento anual da receita nos últimos 3 anos é o crescimento da receita de um ano para o próximo nos últimos 3 anos.

The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.

Receita A/A de empresas na Setor Health Care em TSX em comparação com Theratechnologies

O que Theratechnologies faz?

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Empresas com receita a/a semelhantes a Theratechnologies